NORTH CHICAGO, Ill. , May 28, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 2013 Jeffries Global Healthcare Conference on Tuesday, June 4 , 2013.  Bill Chase , executive vice president and chief financial officer, and Scott Brun , M.D., vice president, pharmaceutical development,

NORTH CHICAGO, Ill. , May 7, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Merrill Lynch 2013 Health Care Conference on Tuesday, May 14 , 2013.  Bill Chase , executive vice president and chief financial officer, and John M.

- Reports First-Quarter Adjusted EPS of $0.68, GAAP EPS of $0.60 - Delivers Revenue of $4.329 Billion, Including 16.0 Percent Global Sales Growth from HUMIRA (Up 17.3 Percent Excluding Foreign Exchange) - Confirms 2013 Adjusted EPS Guidance of $3.03-$3.13, GAAP EPS Guidance of $2.66-$2.76 - All

NORTH CHICAGO, Ill. , April 8, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2013 financial results on Friday, April 26, 2013 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , Feb. 27, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the Barclays Global Health Care Conference on Wednesday, March 13 , 2013.  Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 2:45 p.m.

NORTH CHICAGO, Ill. , Feb. 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the Cowen and Company 33 rd Annual Health Care Conference on Wednesday, March 6 , 2013.  Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 7:40

NORTH CHICAGO, Ill. , Feb. 15, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend and also authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock. The cash dividend of $0.40 per share is payable

HUMIRA delivers 9th year of double-digit growth in 2012; forecasting low double-digit growth in 2013 Advances 11 Phase III programs; HCV Phase III trials underway and on track for early 2015 launch Provides full-year 2013 adjusted EPS guidance of $3.03 to $3.13 ($2.66 to $2.76 on a GAAP basis)

- Abbott will host a conference call to discuss Q4 and full-year 2012 business results and 2013 outlook on Jan. 23, 2013 ­- AbbVie will host a conference call to discuss 2012 business results and 2013 outlook on Jan. 30, 2013 ABBOTT PARK, Ill. and NORTH CHICAGO, Ill. , Jan.

NORTH CHICAGO, Ill. , Jan. 4, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, today declared the Company's first quarterly cash dividend of $0.40 per share.  The cash dividend is payable Feb.